Search Results 311-320 of 16876 for Imiglucerase

  1. Ulcerative colitis - Doctors and departments - Mayo Clinic

    This type of inflammatory bowel disease causes swelling and sores in the digestive tract. Learn more about symptoms, treatment and managing flares.

  2. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    About this study. The purpose of this study is to confirm and extend the results observed in the Phase 1 and 2a studies with BMS-986036.

  3. A Study To Evaluate The Effectiveness And Safety Of Camidanlumab Tesirine (ADCT-301) In Patients With Relapsed Or Refractory Hodgkin Lymphoma - Mayo Clinic

    The purpose of this study is to evaluate the clinical effectiveness and safety of Camidanlumab Tesirine (ADCT-301) in participants with relapsed or refractory ...

  4. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

  5. Insulin glargine and lixisenatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Lixisenatide is to be used when diet and exercise do not result in good blood sugar control. This medicine is available only with your doctor's prescription.

  6. Modulation of Heme Oxygenase 1 by Nizatidine and Lisinopril in Healthy Subjects - Mayo Clinic

    About this study. To assess if oral nizatidine or lisinopril alone and in combination will increase heme oxygenase 1 (HO-1) protein concentration and ...

  7. Neurology - Clinical trials - Mayo Clinic

    The purpose of this study is to determine and compare the safety and efficacy of transcutaneous afferent patterned stimulation (TAPS) and respiratory-gated ...

  8. Aminolevulinic acid (topical route) - Side effects & uses - Mayo Clinic

    Aminolevulinic acid gel is used in combination with photodynamic therapy (PDT) using BF-RhodoLED® or RhodoLED® XL lamps to treat mild to moderate actinic ...

  9. Osimertinib (oral route) - Side effects & dosage - Mayo Clinic

    Description. Osimertinib is used to treat non-small cell lung cancer (NSCLC) in patients who have certain types of abnormal epidermal growth factor (EGFR) ...

  10. Hematology - Clinical trials

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...